Clinical trials offer early access to cutting-edge treatments that can lead to progress in research, improved treatment options, and better outcomes. Through clinical trials, researchers can better understand how to diagnose, treat, and prevent diseases or conditions, which brings us one step closer to a world without autoimmune disease.
The 4WARD Study is a phase 3, randomized, double-blind, placebo controlled, multicenter study of mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenia disorders who are experiencing recurrent and/or serious infections.
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
A phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Obexelimab in patients with relapsing multiple sclerosis.
A phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Obexelimab in patients with systemic lupus erythematosus.
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn’s Disease.
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis.
Browse current studies with filters that allow you to search by condition, treatment, location, and more.
